Fresenius Medical Care wishes you a prosperous and joyful Lunar New Year! As we welcome the Year of the Snake, we celebrate the strength and wisdom it represents. The snake is a transformational symbol. In this Year of the Snake – united by our values, expertise, and dedication to innovation – we are setting new standards of care for patients worldwide. May the Year of the Snake bring good fortune, health, and success to you and your loved ones! #LunarNewYear #YearOfTheSnake #ProudToBeFME

We are happy to share key dates of our 2025 financial reporting schedule. Mark your calendars and stay tuned for insights into our financial performance, business strategy, and market progress on the following dates. You can also visit our Investor Relations page for more information, including events, presentations and resourceful material: freseniusmedicalcare.com/en/… We look forward to continuing our growth story together in 2025! #InvestorRelations #ProudToBeFME

People with diabetes don’t need to cut out carbs! 🌾 Balanced nutrition, including carbohydrates like whole grains, is key. This #WorldDiabetesDay, FME experts debunk 5 myths. 👇Watch the video to learn the truths! #DiabetesLife #DiabetesAwareness

News📢: Fresenius Medical Care reports strong operating income margin growth in the third quarter of 2024. Check out the Q3 earnings information we released today via the press release. We delivered organic revenue growth of +2 % this quarter supported by both segments, Care Enablement and Care Delivery. Dialysis treatment volume growth turned positive in the U.S. market in Q3. The #FME25 transformation program achieved EUR 64 million additional sustainable savings by the end of Q3. With this continued momentum, we accomplished EUR 173 million additional sustainable savings year-to-date – well ahead of our savings goals for the year 2024. Read more in today's press release: freseniusmedicalcare.com/en/… #Reporting #EarningsRelease #QuarterlyReport #Q32024 #InvestorRelations #ProudToBeFME

Marking National Diabetes Month and #WorldDiabetesDay, we celebrate the strength of those living with diabetes, diabetic kidney disease, and their caregivers. 💙🌎 Be inspired by four of our employees who share their stories. #DiabetesLife #DiabetesAwareness

We are delighted to announce the publication of our 2024 Annual Medical Report (AMR), "Advancing and Personalizing Kidney Disease Care." This year's edition illustrates our unwavering commitment to progressing nephrology and kidney care, and the innovative approaches we undertake to care for people with kidney disease. Within the AMR, you'll find a wide range of engaging topics, including our strategy to expand high-volume hemodiafiltration, and our focus on health equity and improving food security. Read our 2024 Annual Medical Report here: freseniusmedicalcare.com/en/… #AnnualMedicalReport #HealthEquity #HighVolumeHDF #HomeDialysis #ProudToBeFME

We’re proud to share that Fresenius Medical Care will participate in EDTNA 2024 in Athens! With around 20 posters and presentations, our diverse team from around the world will showcase innovative research, including the corporate education session, "Is there a place for AI in nursing?" that highlights our commitment to the continued growth of the nursing profession and our dedication to delivering the highest quality care to patients globally. We hope to see you there! #EDTNA2024 #NursingInnovation

We are pleased to announce that Fresenius Medical Care will be attending the ISPD 2024 Congress in Dubai from September 26–29. Join us at booth A111 for an experience that focuses on person-centered care. Click here to register: maarefah.eventsair.com/ispd-…

High-volume hemodiafiltration (HDF) continues to show superior outcomes compared to traditional hemodialysis (HD) for patients with end-stage kidney disease. The CONVINCE study found that high-volume HDF significantly reduces all-cause mortality, particularly infection-related deaths, and improves patient-reported outcomes. These findings suggest that HDF can offer a survival advantage over and above conventional HD, reinforcing its growing role in dialysis treatment. In the latest episode of GMO Dialogues, Dr. @gstrip3, Professor of Nephrology at the University of Bari and Adjunct Professor of Epidemiology at University of Sydney, discusses the pivotal findings of the CONVINCE study, sharing valuable insights into how these findings may influence future dialysis practices for patients with end-stage kidney disease. Watch the latest episode now and dive into the benefits of HDF: youtu.be/muLTV_gQuus #GMODialogues #CONVINCEStudy #MedicalResearch #Dialisys

News📢: Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024. Additional #FME25 savings of EUR 57 million achieved in Q2 2024, and on track to reach the upper end of the full year savings target range. We reduced financial debt further and confirm our financial outlook for the full year 2024. Check out our Q2 earnings we released today: freseniusmedicalcare.com/en/… #Reporting #EarningsRelease #QuarterlyReport #Q22024 #InvestorRelations

At today’s #AGM2024, 88.39 percent of the share capital was represented. 214 shareholders in person joined the event on site at the Congress Center Messe Frankfurt, Germany. Read the voting results here: freseniusmedicalcare.com/en/… #AnnualGeneralMeeting #InvestorRelations

Our nurses are selfless, compassionate, and resilient, as described by Antonio, a dialysis patient. They transform lives with their exceptional care for people living with chronic kidney disease. 💙 🌟 Explore their inspiring stories here: freseniusmedicalcare.com/en/… #INDatFME

We're thrilled to announce our HighVolumeHDF Scientific Dinner event, which will be held in Stockholm on May 24th. Exclusive to ERA Congress attendees. If you are interested, please submit your application here: tinyurl.com/Scientific-Dinne… #ERA24 #DialysisInnovation

News📢: Fresenius Medical Care starts the year 2024 with strong earnings growth. Solid revenue growth of 4% driven by both segments Care Delivery and Care Enablement. Read more in our press release here: freseniusmedicalcare.com/en/… #EarningsRelease #QuarterlyReport #Q12024

Kicking off our global #InternationalNursesDay celebrations 🎉 Grateful for our incredible nurses and care teams at Fresenius Medical Care. Your compassion, daily acts of kindness and dedication change lives. Everything you do makes the difference. Thank you! 🩺💙 #INDatFME

At #FreseniusMedicalCare we celebrate the #WorldDayForSafetyandHealthAtWork by reflecting on emerging risks influencing our workforce. Find out more about our Occupational Health and Safety efforts on our Annual Report: freseniusmedicalcare.com/en/…

Mark your calendars! 📅 On May 7th, Fresenius Medical Care will release the first quarter earnings. #SaveTheDate to be among the first to read our press release! #Reporting #EarningsRelease #QuarterlyReport #Q12024 #InvestorRelations

2M worldwide battle kidney failure, often with renal anemia complicating treatment. In the new GMO Dialogues episode, Dr. Luca Neri discusses using AI & computational modeling in anemia management. Watch now to get more insights: youtu.be/J63wC47sBAM

Our CEO Helen Giza sat down with @JudyKShaw from @NYSE for their Floor Talk segment to discuss our transformational journey and the exciting path forward. #TogetherAhead #ProudtobeFME #NYSEFloorTalk

#News: Fresenius Medical Care delivers on its portfolio management program, announcing the sale of its dialysis clinic networks in Brazil, Colombia, Chile and Ecuador to DaVita Inc., for a total transaction price of USD 300 million. Read the #PressRelease freseniusmedicalcare.com/en/…